Vermillion Inc., of Austin, Texas, received a notice of allowance for a patent, titled "Platelet biomarkers for cancer," identifying three biomarkers that can be used to assess changes in endogenous angiogenesis in a subject

Vermillion Inc., of Austin, Texas, received a notice of allowance for a patent, titled "Beta-2 Microglobulin (B2m) and C Reactive Protein (CRP) as Biomarkers for Peripheral Artery Disease

Vermillion Inc., of Austin, Texas, received U.S. Patent No

Vermillion Inc., of Austin, Texas, received a notice of allowance for a patent, titled "Biomarkers for Peripheral Artery Disease

Vermillion Inc., of Austin, Texas, received a notice of allowance for a patent, titled "Biomarkers for Peripheral Artery Disease

Vermillion Inc., of Austin, Texas, received a notice for allowance for a patent, titled "Panel of Biomarkers for Peripheral Artery Disease

Vermillion Inc., of Austin, Texas, received U.S. Patent No

Vermillion Inc., of Fremont, Calif., received a notice of allowance for a patent titled "Biomarkers for Alzheimer's disease," covering biomarker combinations for the diagnosis and management of Alzheimer's and to the measurement of biomarkers by a variety of methods

Vermillion Inc., of Fremont, Calif., received U.S. Patent No

Vermillion Inc., of Fremont, Calif., received a notice of allowance for a patent covering the discovery of hepcidin as a biomarker for ovarian cancer

Vermillion Inc., of Fremont, Calif., received U.S. Patent No

Vermillion Inc., of Fremont, Calif., received U.S. Patent No